Navigation Links
BioMS Medical to present at 2008 BIO International Convention
Date:6/12/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, June 12 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Business Forum at the 2008 BIO International Convention in San Diego, California.

WHEN: Friday June 20th at 10:15 am (PDT)

WHERE: San Diego Convention Center, San Diego

About the 2008 BIO International Convention

The 2008 BIO International Convention, hosted by the Biotechnology Industry Organization, will feature keynotes from industry and global leaders, more than 175 breakout sessions, business partnering meetings, and numerous networking events. The convention also includes more than 200,000 square feet of exhibitions showcasing the latest advancements in biotechnology alongside an array of potential partners, service providers, and state and international delegations. For more information visit http://www.bio2008.org/.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298 (dirucotide), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide) in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
2. BioMS Medical announces first quarter 2008 results
3. BioMs Medical to present at TIDES(R) Conference
4. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
5. BioMS Medical Provides Update On Pipeline Products
6. BioMS Medical announces conference call and web cast for Annual General Meeting
7. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
8. BioMS Medical to present at EQUITIES Conference
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medical to present at BioCentury Conference
11. BioMS Medical Announces 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... - Aegera Therapeutics announced today,the initiation of ... AEG33773, a,novel, orally bioavailable small molecule in ... The Phase I study will evaluate the ... a randomized,double blind, placebo controlled, single ascending ...
... that improve the, safety, effectiveness, and environmental impact of ... new denitrification ... products-, ... today that the company has closed the first,tranche of a $2.5 ...
... Litigation with US Labs, FT. MYERS, Fla., March ... its results for the fourth,quarter and full year of ... year included the following:, Fourth Quarter 2007 ... of 115% year-over-year from Q4 06 -- Avg. ...
Cached Biology Technology:Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain 2Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 2Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 3Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 4NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 2NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 3NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 4NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 5NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 6NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 7NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 8NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007 9
(Date:4/16/2014)... Boulder, Colorado, USA - Geoscientists from the north-central U.S. ... 24-25 April to discuss new science, expand on existing ... of the region, with a special emphasis on applied ... talk at 7 p.m. on Thursday by Dr. Kirk ... Natural History. , The meeting is hosted by ...
(Date:4/16/2014)... or to conquer the world? Surprisingly, bacteria also ... in Munich have now shown how these organisms ... , The bacterium Bacillus subtilis is ... on agar surfaces by means of flagella. Alternatively, ... the bacteria proliferate most effectively in this stationary ...
(Date:4/15/2014)... UC Irvine neurobiologists have found that genetically modified neural ... brains of mice with the symptoms and pathology of ... journal Stem Cells Research and Therapy , and ... different mouse models. , Alzheimer,s disease, one of ... accumulation of the protein amyloid-beta in the brain in ...
Breaking Biology News(10 mins):Walking with mammoths and exploring mid-continental geology 2Walking with mammoths and exploring mid-continental geology 3Walking with mammoths and exploring mid-continental geology 4Theoretical biophysics: Adventurous bacteria 2UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2
... University researchers have discovered men with an unusual form ... men the same age who are cognitively normal. , ... disease in which people have trouble recalling and understanding ... themselves and understand speech. It differs from typical Alzheimer's ...
... study in Switzerland uses the tools of physics to ... time in the noisy cellular environment. , In ... Systems Biology, researchers from the Ecole Polytechnique Federale de ... on specific biochemical processes, reflecting recent association studies in ...
... A complex molecule and snake venom may provide researchers ... and developing new drugs. , Purdue University researchers bound ... identification tag that was delivered to specific proteins in ... to find a better way to ascertain the presence, ...
Cached Biology News:Vasectomy may put men at risk for type of dementia 2Vasectomy may put men at risk for type of dementia 3Keeping the body in sync -- The stability of cellular clocks 2Scientists use nanoparticle to discover disease-causing proteins 2
... combines a single-channel sample processing head, an ... reagent dispenser all in one compact, affordable ... pipette tips, the Precision XS autoclavable and ... available for transferring larger volumes. Intuitive Precision ...
... races ever faster, you need a partner who ... our constant focus is on providing tools and ... our Biomek 3000 Laboratory Automation Workstation offers a ... is flexible. By integrating all aspects of liquid ...
... Rabbit Tissue Arrays contain 60 rabbit tissue samples ... contains 4 unstained slides and 1 hematoxylin and ... slide contains 15 different tissues from 4 rabbit ... per slide. Each tissue sample (or core) is ...
... with a wide variety of purity levels, scales ... Purity: IG(>50%), >70%, >80% and ... Sequence Length: Up to 120 residues ... D-amino acids, MAPs, KLH/BSA conjugation, and much more. ...
Biology Products: